The CXCL10 level was found to be increased in the plasma of untreated and treatment-refractory patients with Mycobacterium avium complex (MAC)-induced lung diseases, suggesting a role of CXCL10 as a marker of NTM disease [50]. The gene discussed is CXCL10; the disease is lung disorder.